Urokinase Therapy in Diabetic Foot Syndrome
Phase 2
Completed
- Conditions
- IschemiaDiabetic FootArterial Occlusive Disease
- Interventions
- First Posted Date
- 2007-10-01
- Last Posted Date
- 2010-03-25
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 77
- Registration Number
- NCT00537498
- Locations
- 🇩🇪
Universitätsklinikum Carl Gustav Carus UniversitätsGefäßcentrum, Dresden, Germany
Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid
Phase 3
Completed
- Conditions
- Brain CancerBrain TumorsCancer of BrainPrimary Brain TumorsBrain Tumor, Primary
- Interventions
- Drug: 5-aminolevulinic acid (5-ALA)
- First Posted Date
- 2005-10-19
- Last Posted Date
- 2012-04-26
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 415
- Registration Number
- NCT00241670
© Copyright 2025. All Rights Reserved by MedPath